Jan Winkel is the founder of Genmab. Genmab has raised $234M in total funding. Latest round: IPO. Based in Utrecht, Netherlands.
Jan van de Winkel is the Co-founder, President, and Chief Executive Officer of Genmab A/S, an international biotechnology company focused on developing antibody drugs for cancer and other serious diseases. He has led Genmab as CEO since its founding in 1999 and through its record IPO in 2000.
Full founder directory · Investor directory · Company funding database · Fundraising library